Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.3.1.900
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Revenues, net:    
Product $ 10,908,704 $ 10,973,544
Recurring 4,175,222 3,822,987
Total Net Revenue 15,083,926 14,796,531
Cost of Sales:    
Product 5,734,954 6,504,630
Recurring 1,010,662 1,053,215
Total Cost of Sales 6,745,616 7,557,845
Gross Profit 8,338,310 7,238,686
Operating Expenses:    
Research and development 1,605,667 1,312,488
Selling, general and administrative 6,381,727 5,366,006
Depreciation and amortization 273,507 275,236
Total Operating Expense 8,260,901 6,953,730
Income from Operations 77,409 284,956
Other (Expenses) Income:    
Interest (expense) income, net (69,441) (40,273)
Total Other (Expenses) (69,441) (40,273)
Income Before Provision for Income Taxes 7,968 244,683
Provision for Income Taxes 197,072 201,853
Net (Loss) Income (189,104) 42,830
Accretion of preferred dividends and discount (18,253) (138,233)
Net loss attributable to common stockholders $ (207,357) $ (95,403)
Net loss per common share:    
Net loss attributable to common stockholders per common share - basic $ (0.00) $ 0.00
Net loss attributable to common stockholders per common share - diluted $ (0.00) $ 0.00
Weighted Average Common Shares Outstanding - basic 125,859,903 125,035,612
Weighted Average Common Shares Outstanding - diluted 125,859,903 125,035,612